and Rand, C.
, “Medication Non-Adherence and Asthma Treatment Cost,” Current Opinion in Allergy and Clinical Immunology 4
, no. 3
; B.A. Briesacher, J.H. Gurwitz, and S.B. Soumerai, “Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature,” Journal of General Internal Medicine
22, no. 6 (2007): 864-871; M.T. Brown and J.K. Bussell, “Medication Adherence: WHO Cares?” Mayo Clinic Proceedings
86, no. 4 (2011): 304-314; N.K. Choudhry, J. Avorn, R.J. Glynn, E.M. Antman, S. Schneeweiss, M. Toscano, et al., “Full Coverage for Preventive Medications after Myocardial Infarction,” New England Journal of Medicine
365, no. 22 (2011): 2088-2097; N.K. Choudhry, T.D. Denberg, and A. Qaseem, “Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities from the Greater use of Generic Medications: Best Practice Advice from the Clinical Guidelines Committee of the American College of Physicians,” Annals of Internal Medicine
164, no. 1 (2016): 41-49.CrossRefGoogle Scholar